TATAA Biocenter Expands Its Next-Generation Sequencing Offerings with HTG Molecular Diagnostics’ Unique HTG EdgeSeq System
HTG Molecular Diagnostics Fulfills First Orders for its Next-Generation Sequencing-Based HTG EdgeSeq Precision Immuno-Oncology Panel
HTG Molecular Diagnostics and Oncologie Complete Master Agreement to Partner on Biomarker Development for Immuno-oncology Drug Development
Element79 Gold Corp Announces Corporate Update and Strategic Leadership Changes With Focus On Accelerating Nevada Asset Development
